Company intelligence / Profile preview

Skincolor

France
Ownership
Private
Development stage
Other
01

Overview

Skin color is a France-based biotechnology company founded in 2019 that specializes in the development of genetic models for predicting human phenotypes. The company's primary product is a scientific tool designed to estimate a baby's likely skin tone based on the genetic information and skin tones of parents and grandparents. By utilizing a refined dominance hierarchy and analyzing polygenic inheritance patterns, the platform provides probability-based results across a broad spectrum of skin tone categories. The company aims to offer scientifically-grounded insights into the inheritance of skin pigmentation for both clinical and consumer applications.

Therapeutic areas
Other
Modalities
Genetic modelSoftware
Industry
Non-Drug Biotech

Beyond the preview

Go deeper on Skincolor.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skincolor.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call